As a key risk factor for heart failure (HF), pathological cardiac hypertrophy (PCH) results from many factors and regulators, especially renin‐angiotensin‐aldosterone system (RAAS) and its primary effector peptide angiotensin II (Ang II).1 Here, AGT is linked to heart failure.